Commercial Credit Report for Analytica Limited

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Analytica Limited is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Analytica Limited
PO Box 438
Phone: +61 732781950p:+61 732781950	MARYBOROUGH, QLD 4650 Australia	Fax: +61 732598313f:+61 732598313

This company is no longer actively traded on any major stock exchange.

Business Summary

Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2022	6/30/2022	Yes	-	-	-	-

Industries

SIC Code	Description
3841	Surgical and medical instruments and apparatus

Officers and Directors

Title	Name	Age	Title Date	Start Date
Executive Chairman of the Board	MichaelMonsour		3/28/2006	6/28/2004
Chief Financial Officer, Company Secretary	BryanDulhunty		3/11/2014	6/19/2002
Director	Peter B.Corr	74	5/23/2017	5/23/2017
Non-Executive Independent Director	RossMangelsdorf		9/26/2014	10/7/2008

General Information

Number of Employees:	2	(As of 6/30/2005)
Outstanding Shares:	4,613,801,129	(As of 12/31/2022)
Shareholders:	1,271
Stock Exchange:	ASX
Fax Number:	+61 732598313
Email Address:	reception@analyticamedical.com